Importer of Controlled Substances Application: Cambrex Charles City, 30982 [2021-12215]
Download as PDF
<![CDATA[
30982
Federal Register / Vol. 86, No. 110 / Thursday, June 10, 2021 / Notices
Management Ltd, London, UNITED
KINGDOM; Ameren Services, St. Louis,
MO; Anterix, Woodland Park, NJ; ATT
Business, Dallas, TX; BEC Technologies,
Richardson, TX; Blinq Network,
Markham, CANADA; Bridgewater
Group Consulting, Irvine, CA; Burns
and McDonnell, Kansas City, MO; Cisco,
San Jose, CA; Council Rock, Rochester,
NY; CrescoNet, San Francisco, CA;
Encore Networks, Chantilly, VA;
Ericsson, Plano, TX; Evergy, Kansas
City, MO; GE Industrial
Communications, Rochester, NY;
Hitachi-ABB, Raleigh, NC; JEA,
Jacksonville, FL; K and A Engineering,
White Plains, NY; L3 Harris, Rochester,
NY; Mimomax Wireless, Christchurch,
NEW ZEALAND; Motorola Solutions,
Chicago, IL; Multi Tech Systems,
Mounds View, MN; Nokia, Coppell, TX;
NovaTech, Lenexa, KS; National Rural
Telecommunications Cooperative,
Herndon, VA; NY Power Authority
(NYPA), White Plains, NY; Palmetto
Technology Associates, Kiawah Island,
SC; Puloli, Inc., San Francisco, CA;
Southern California Edison, Rosemead,
CA; SouthernLinc, Atlanta, GA; Telit
Wireless Solutions, Durham, NC; World
Wide Technology, Maryland Heights,
MO; and Xcel Energy, Minneapolis, MN.
UBBA was formed as a Delaware nonstock member corporation. The general
area of UBBA’s planned activity is to
empower utilities and ecosystem
partners to champion the development
of utility broad-band networks as a key
enabler of the utility of the future, and
to undertake such other activities as
may from time to time be appropriate to
further the purposes and achieve the
goals set forth above.
Membership in UBBA remains open
and UBBA intends to file additional
written notifications disclosing all
changes in membership.
Suzanne Morris,
Chief, Premerger and Division Statistics,
Antitrust Division.
[FR Doc. 2021–12180 Filed 6–9–21; 8:45 am]
BILLING CODE 4410–11–P
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before July 12, 2021. Such persons
may also file a written request for a
hearing on the application on or before
July 12, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on May 6, 2021, Cambrex
Charles City, 1205 11th Street, Charles
City, Iowa 50616–3466, applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
Drug
code
Controlled substance
4-Anilino-N-Phenethyl4-Piperidine (ANPP).
Phenylacetone ..............
Coca leaves ..................
Opium, raw ...................
Poppy Straw Concentrate.
Drug Enforcement Administration
[Docket No. DEA–847]
Importer of Controlled Substances
Application: Cambrex Charles City
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
William T. McDermott,
Assistant Administrator.
Cambrex Charles City has
applied to be registered as an importer
BILLING CODE 4410–09–P
AGENCY:
SUMMARY:
VerDate Sep<11>2014
17:15 Jun 09, 2021
Jkt 253001
Schedule
8333
II
8501
9040
9600
9670
II
II
II
II
The company plans to import the
listed controlled substances for internal
use and to bulk manufacture other
controlled substances in Active
Pharmaceutical Ingredient (API) form
for distribution to its customers. No
other activity for these drug codes is
authorized for this registration.
DEPARTMENT OF JUSTICE
khammond on DSKJM1Z7X2PROD with NOTICES
of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
[FR Doc. 2021–12215 Filed 6–9–21; 8:45 am]
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–844]
Importer of Controlled Substances
Application: Fisher Clinical Services,
Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Fisher Clinical Services, Inc.
has applied to be registered as an
importer of basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before July 12, 2021. Such persons
may also file a written request for a
hearing on the application on or before
July 12, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on May 17, 2021, Fisher
Clinical Services, Inc. 7554 Schantz
Road, Allentown, Pennsylvania 18106–
9032 applied to be registered as an
importer of the following basic class(es)
of controlled substance(s):
SUMMARY:
Controlled substance
Marihuana Extract ........
Drug
code
7350
Schedule
I
The company plans to import the listed
controlled substances for clinical trails
only. No other activity for these drug
codes is authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
E:\FR\FM\10JNN1.SGM
10JNN1
]]>Agencies
[Federal Register Volume 86, Number 110 (Thursday, June 10, 2021)]
[Notices]
[Page 30982]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-12215]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-847]
Importer of Controlled Substances Application: Cambrex Charles
City
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Cambrex Charles City has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before July 12, 2021.
Such persons may also file a written request for a hearing on the
application on or before July 12, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on May 6, 2021, Cambrex Charles City, 1205 11th Street,
Charles City, Iowa 50616-3466, applied to be registered as an importer
of the following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
4-Anilino-N-Phenethyl-4-Piperidine 8333 II
(ANPP).
Phenylacetone.......................... 8501 II
Coca leaves............................ 9040 II
Opium, raw............................. 9600 II
Poppy Straw Concentrate................ 9670 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
internal use and to bulk manufacture other controlled substances in
Active Pharmaceutical Ingredient (API) form for distribution to its
customers. No other activity for these drug codes is authorized for
this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-12215 Filed 6-9-21; 8:45 am]
BILLING CODE 4410-09-P
